Judge Will Hear GSK's Arguments To Dismiss Zofran MDL
A Boston federal judge said Thursday that he would hear GlaxoSmithKline's arguments on dismissing some cases and claims from multidistrict litigation linking the anti-nausea drug Zofran to birth defects, overruling the...To view the full article, register now.
Already a subscriber? Click here to view full article